Clinical Trials Browser

Phase 2/3 × masitinib × Clear all

NCT02490488 2020-12-08

Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients

Phase 2/3 Completed

Ovarian Neoplasms

NCT03556956 2020-12-08

Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer

Phase 2/3 Completed

Gastrointestinal

Colorectal Cancer Metastatic